Till date, there is no cure for dementia but there are multiple treatments that can help one manage ... there are things we ...

If approved by the FDA, Darzalex Faspro may be the first treatment for smoldering multiple myeloma as compared to treating the disease once it progresses.

Johnson & Johnson seeks US & EU approvals for Darzalex Faspro/Darzalex as subcutaneous monotherapy for high-risk smoldering multiple myeloma: Raritan, New Jersey Monday, November ...

The marketing applications with the EMA and FDA are for J&J and partner Genmab's Darzalex Faspro version of the anti-CD38 ...

Raritan: Johnson & Johnson has announced the submission of regulatory applications to the U.S. Food and Drug Administration ...

The companies’ CAR-T seemed to cause fewer movement disorders in a multiple myeloma trial than J&J's Carvykti has in other ...

New data will showcase significantly increased and sustained minimal residual disease (MRD) negativity rates, reinforcing the potential of CARVYKTI to transform outcomes in refractory multiple myeloma ...

The early stages of kidney disease often ... disease is close to an advanced stage. The most common signs and symptoms of multiple myeloma are abbreviated with the acronym CRAB.

According to a GP, there are some early signs of dementia that may be noticeable even before memory loss. Dementia is a progressive condition that affects brain function, leading to a decline in ...

Signs of the disease can also show up in the way someone moves, studies show. A recent piece of research indicated that changes to someone's pace when they walk could be an early indicator of ...

The signs of both are the same. “Early recognition of a stroke is crucial – it can save lives and prevent long-term disability,” says Dr Branimir Nevajda, a consultant in neurology and ...

DelveInsight’s Refractory Multiple Myeloma pipeline report depicts a robust space with 75+ active players working to develop ...